Pathogenic mycobacteria, which cause multiple diseases including tuberculosis, secrete factors essential for disease via the ESX-1 protein export system and are partially protected from host defenses by their lipid-rich cell envelopes. These pathogenic features of mycobacterial biology are believed to act independently of each other. Key ESX-1 components include three ATPases, and EccA1 (Mycobacterium marinum MMAR_5443; M. tuberculosis Rv3868) is the least characterized. Here we show that M. marinum EccA1's ATPase activity is required for ESX-1-mediated protein secretion, and surprisingly for the optimal synthesis of mycolic acids, integral cell-envelope lipids. Increased mycolic acid synthesis defects, observed when an EccA1-ATPase mutant is expressed in an eccA1-null strain, correlate with decreased in vivo virulence and intracellular growth. These data suggest that two mycobacterial virulence hallmarks, ESX-1-dependent protein secretion and mycolic acid synthesis, are critically linked via EccA1.
INTRODUCTION
Mycobacterium tuberculosis has infected one-third of all people and kills two million people every year (Koul et al., 2011; Lö nnroth et al., 2010) . The disease burden is worsened because mycobacteria are becoming increasingly resistant to antibiotics. Despite this, no new antimycobacterial antibiotic has been brought to clinical use for almost 50 years, and many mycobacterial pathogenic mechanisms, which might provide novel drug targets, are only beginning to be understood (Koul et al., 2011) .
Mycobacteria are resistant to many of the bactericidal mechanisms of host immunity, at least in part because of their cell envelope composed primarily of mycolic acids (Niederweis et al., 2010) . These mycolic acids are covalently attached to underlying arabinogalactan-peptidoglycan and likely form the inner leaflet of an asymmetric outer membrane, whose outer leaflet is composed of diverse lipids (Hoffmann et al., 2008; Minnikin et al., 2002; Niederweis et al., 2010) . Many of these surface-exposed lipids, such as trehalose dimycolate (TDM), phthiocerol dimycocerosate (PDIM), and phenolic glycolipid (PGL), are implicated in mycobacterial virulence (Chopra and Gokhale, 2009; Minnikin et al., 2002) . Moreover, even minor mycolate structural changes have major effects on mycobacterial virulence (Dubnau et al., 2000; Glickman et al., 2000; Yuan et al., 1998) . Thus, cell-wall mycolates and their associated lipids are major factors in the ability of mycobacteria to cause disease in metazoan hosts.
Little is known about how mycobacteria move proteins and other macromolecules across this unusual cell envelope. An export system, ESX-1 (Abdallah et al., 2007; Bitter et al., 2009) , is required for protein secretion critical to the virulence of pathogenic mycobacteria including M. tuberculosis and its close genetic relative, M. marinum (Gao et al., 2004) , a natural pathogen of fish and frogs that causes a systemic tuberculosis-like infection in these hosts (Cosma et al., 2003) . ESX-1 is composed largely of proteins encoded by a genetic locus that is altered or partially deleted in closely related nonpathogenic species such as the vaccine strain of Mycobacterium bovis, Bacillus CalmetteGuerin, and Mycobacterium microti (Abdallah et al., 2007; Lewis et al., 2003; Pym et al., 2002) . Key components of the ESX-1 protein secretion system include three ATPases: EccCa1 (M. marinum MMAR_5445; M. tuberculosis Rv3870) (ESX core component [Ecc] Ca1) and EccCb1 (M. marinum MMAR_5446;
M. tuberculosis Rv3871), which are thought to function in transport of proteins across the cytosolic membrane (Abdallah et al., 2007; Bitter et al., 2009) , and EccA1 (M. marinum MMAR_5443; M. tuberculosis Rv3868), a protein whose role in the ESX-1 system, although essential (Gao et al., 2004) , is less well characterized. EccA1 contains two predicted domains, an N-terminal tetratricopeptide repeat domain and a C-terminal AAA ATPase domain ( Figure 1A ). M. tuberculosis EccA1 forms homohexamers like other AAA ATPase proteins and has measurable ATPase activity (Luthra et al., 2008) . However, it is unclear whether EccA1's ATPase activity is important for its cellular function, which also is poorly defined. Here we show that an ATPase-defective mutant of EccA1 unexpectedly binds several enzymes involved in cell-envelope biogenesis and impedes mycolic acid synthesis. Moreover, an eccA1-null M. marinum strain expressing this mutant is attenuated in vivo and more defective for intracellular growth in macrophages, even though the eccA1-null strain already is defective in ESX-1-mediated secretion. Thus, EccA1 is involved in two previously unlinked virulence-associated pathways.
RESULTS
EccA1's ATPase Activity Is Needed to Secrete ESAT-6 and Lyse Cells To gain insight into EccA1's function and to determine whether EccA1's ATPase activity is needed, we constructed an M. marinum EccA1 point mutant, E398Q (EQ), that lacks the catalytic glutamic acid in the conserved nucleotide-binding site and is likely an ATP-locked form of EccA1 because it cannot hydrolyze ATP (Hanson and Whiteheart, 2005; Zhang and Wigley, 2008 ) (see Figure S1 available online). Wild-type or mutant eccA1 was expressed in a previously characterized eccA1 transposon-disrupted mutant strain, eccA1::Tn (Gao et al., 2004) . Immunoblotting with an anti-EccA1 antibody detected no EccA1 in eccA1::Tn cells, confirming the antibody specificity, whereas similar levels of wild-type or mutant EccA1 were detected in complemented strains ( Figure 1B ). EccA1 deficiency inhibited secretion of ESAT-6, an archetypal ESX-1 substrate (Abdallah et al., 2007; Gao et al., 2004) , whereas expression of wild-type EccA1 restored secretion ( Figure 1C ). Reconstitution of eccA1::Tn with the EQ mutant did not, demonstrating that EccA1's ATPase activity is required to secrete ESAT-6. In addition, eccA1::Tn lacked the ability to lyse red blood cells, a property previously demonstrated to require ESX-1 (Gao et al., 2004) . This defect was complemented by wild-type EccA1, but not by EQ EccA1 ( Figure 1D ). Thus, two assays of ESX-1 function demonstrate a requirement for EccA1 ATPase activity.
EQ EccA1 Interacts with Lipid Synthases
Studies using similar ATPase-defective mutants have identified both functional roles where nucleotide hydrolysis is needed as well as partner proteins preferentially binding to the ATP-bound form of the protein of interest (Hanson and Whiteheart, 2005; Zhang and Wigley, 2008) . We therefore tested whether EQ EccA1 interacted more strongly with some partner proteins in order to gain insight into EccA1's cellular role. SDS-PAGE analyses of cytosolic complexes containing wild-type or EQ EccA1 showed that many more proteins larger than 100 kDa copurified with EQ EccA1 than did with wild-type EccA1 (Figure 2A) . These coprecipitated proteins were identified by mass spectrometry (Tables S1 and S2 ). Whereas the numbers of (B) Wild-type and plasmid-encoded wild-type or EQ EccA1 are expressed at similar levels. CF, culture filtrate; CL, whole-cell lysate; GroEL, a loading control. (C) EQ-EccA1 expression cannot restore ESAT-6 secretion. Ag85 complex is a loading control, and 8-fold more normalized CF than CL was analyzed in the Ag85 blot, whereas a 1:1 CF:CL ratio was analyzed in all other blots. (D) Wild-type EccA1 complements eccA1::Tn's hemolytic defect, but EQEccA1 expression is similar to the buffer control. Averaged data are from three independent experiments and are mean values ± SEM. See also Figure S1 . EccA1-derived peptides were similar in bacterial samples expressing either wild-type or EQ EccA1, EQ-containing complexes were enriched for multiple proteins involved in mycobacterial lipid synthesis (Bhatt et al., 2007; Chopra and Gokhale, 2009; Minnikin et al., 2002) including Pks13, KasB, KasA, MmaA4, Pks5, Mas, Pks15/1, PpsD, and PpsE ( Figure 2B ), as detected either by total peptides isolated (top) or when normalized to peptides found in the eccA1::Tn sample (bottom). Pks13, KasB, KasA, and MmaA4 are important enzymes in the fatty acid synthase II (FAS-II) system that makes mycolic acid and mycolate-containing lipids such as TDM (Bhatt et al., 2007; Dubnau et al., 2000; Takayama et al., 2005; Veyron-Churlet et al., 2005) , whereas four of the other enzymes are polyketide synthases that produce PDIM and/or PGL, two other surfaceexposed lipids (Chopra and Gokhale, 2009; Minnikin et al., 2002) . We did not detect evidence of interaction under these conditions with a previously reported binding partner, EspC (DiGiuseppe Champion et al., 2009) . To verify enzyme association with EQ EccA1, antibodies were raised against an enzyme involved in mycolate synthesis, Pks13, and one involved in polyketide synthesis, Mas ( Figure S2A ). Whereas all strains produced similar amounts of Pks13 and Mas ( Figure S2B ), immunoblotting showed more coisolation with EQ EccA1 than with wild-type ( Figure 2C , left). Normalized for the amount of isolated EccA1, quantities of coprecipitated Pks13 and Mas were approximately 2-fold greater with EQ than with wild-type ( Figure 2C , right).
EccA1
Interacts with Pks13 1-1340 , KasB, KasA, and MmaA4 To determine whether interaction between EccA1 and these enzymes involved in mycolic acid synthesis depends on other mycobacterial proteins, their interaction was assessed in an Escherichia coli bacterial two-hybrid system (McLaughlin et al., 2007) . Wild-type and mutant EccA1 interact with Pks13 1-1340 , KasB, and KasA in this assay ( Figure 2D ) to the same extent as wild-type EccA1 and PPE68 (M. marinum MMAR_5448; M. tuberculosis Rv3873), whose interaction has been documented previously (Teutschbein et al., 2009) . Interaction with MmaA4 also occurs, but to a lesser extent ( Figure 2D ). All mycobacterial proteins were expressed to a similar extent in E. coli ( Figure S2C ). There was no difference in interactions with wild-type or EQ EccA1 in E. coli, suggesting that additional mycobacterial proteins regulate these interactions in 
EQ EccA1 Interacts More Stably with Lipid Synthases
(A) Cytosolic complexes containing EccA1 were isolated and visualized by SDS-PAGE and silver staining. EQ EccA1 coprecipitates more proteins larger than 100 kDa compared to wild-type. (B) Mass spectrometric analyses of coprecipitating proteins identified multiple polyketide synthases as interacting better with EQ EccA1. (C) Immunoblotting of coprecipitation reactions with specific antibodies shows more Pks13 and Mas interacting with EQ EccA1 (left). Quantitated values from two independent experiments are shown (right). (D) All EccA1 variants interact with Pks13 1-1340 , KasB, and KasA as strongly as a control in a two-hybrid experiment, and less well with MmaA4. Percent interaction is calculated from the ratio of colonies on selective plates to those on nonselective plates. Averaged data are from two or more independent experiments, and mean values ± SEM are shown. See also Figure S2 and Tables S1 and S2. mycobacteria or that the known interactions among Pks13, KasB, KasA, and MmaA4 (Veyron-Churlet et al., 2005) regulate binding to EccA1.
EccA1 Enhances Mycolic Acid Synthesis
Pks13's main function is to condense together the two fatty acid chains that comprise mycolic acids, the longer meromycolate chain produced by FAS-II and the shorter a branch produced by the fatty acid synthase I (FAS-I) complex (Bhatt et al., 2007; Portevin et al., 2004; Takayama et al., 2005) . KasB and KasA are integral components of FAS-II (Veyron-Churlet et al., 2004 and help make the meromycolate chain that Pks13 condenses with the a branch (Bhatt et al., 2007; Takayama et al., 2005) , whereas MmaA4 is a methyltransferase that modifies the meromycolate chain (Dinadayala et al., 2003; Yuan and Barry, 1996) as it is elongated by FAS-II.
We therefore tested whether mycobacterial strains lacking functional EccA1 have defects in mycolic acid synthesis. Three distinct types of mycolic acids (alpha, methoxy, and keto) exist in M. marinum (Daffé et al., 1991) , like in M. tuberculosis (Bhatt et al., 2007; Minnikin et al., 2002; Takayama et al., 2005) . Regardless of EccA1 expression, all three classes of mycolic acids incorporated radiolabeled [1-
14 C]-tetracosanoic acid ( Figure 3A ). However, eccA1::Tn produced 30%-40% less total mycolic acid than wild-type ( Figure 3B ). Wild-type EccA1 complemented this defect, but EQ EccA1 did not ( Figure 3B ), demonstrating that EccA1's ATPase activity is necessary for optimal mycolic acid production in M. marinum.
EQ EccA1 Sensitizes Cells to Mycolic Acid Stress
To determine the functional significance of the decreased mycolate synthesis, we examined the response of eccA1::Tn and (eccA1::Tn)/EQ to ethionamide, an antibiotic that inhibits mycolic acid synthesis, by monitoring their mycolic acid production in the presence of 0.5 mg/ml ethionamide ( Figure 4A, left) , an antibiotic concentration likely below the minimum inhibitory concentration (Heifets, 1988) . Mycolic acid production was equivalently inhibited by ethionamide in wild-type and eccA1::Tn ( Figure 4A, left) . Interestingly, mycolate production was 2-fold more inhibited in the strain expressing EQ EccA1 than in wildtype, eccA1::Tn, or (eccA1::Tn)/WT ( Figure 4A , left), suggesting that EQ-EccA1 expression further sensitized mycobacteria to stress affecting mycolic acid production, possibly because EQ EccA1 sequestered some of the enzymes involved in the mycolate synthesis pathway. Increased sensitivity to ethionamide was demonstrated as well by ethionamide's lower half-maximal growth-inhibitory concentration (IC 50 ) for the EQ-EccA1 expressing strain ( Figure 4A , right). This suggests that stable EQ-EccA1 interaction with FAS-II enzymes amplifies the defect in mycolate synthesis induced by ethionamide, since expression of wild-type EccA1 did not increase sensitivity to the antibiotic. Moreover, sensitization by EQ EccA1 to ethionamide appeared specific because neither eccA1::Tn nor (eccA1::Tn)/ EQ was more sensitive to two hydrophobic antibiotics, rifampin and erythromycin ( Figure 4B ). The increased resistance of eccA1::Tn and (eccA1::Tn)/EQ to rifampin and erythromycin compared to wild-type suggests that their decreased mycolic acid production did not result in a simple permeability defect, as has been reported for a kasB-null strain (Gao et al., 2003) .
EQ EccA1 Decreases Virulence in Zebrafish and Intracellular Growth in Macrophages
Protein secretion through ESX-1 is important for M. marinum virulence (Gao et al., 2004) , and both eccA1::Tn and (eccA1::Tn)/EQ do not secrete ESAT-6 ( Figure 1C ). Because (eccA1::Tn)/EQ made significantly less mycolic acid when mycolate synthesis was stressed ( Figure 4A , left), we tested whether EQ EccA1 would distinctly affect M. marinum virulence in zebrafish, a situation likely to require maximal mycolic acid synthesis both for bacterial growth and to repair cell-envelope damage from host defenses (Bhatt et al., 2007; Lacave et al., 1989; Niederweis et al., 2010; Rachman et al., 2006; Takayama et al., 1972) . To perform these experiments, wild-type or EQ eccA1 was integrated into the chromosome at the attB site (Stover et al., 1991) to maintain stable expression during the relatively long time frame of the zebrafish experiments. Like plasmidexpressed EccA1 (Figure 1B) , wild-type and mutant EccA1 were expressed at equivalent levels (data not shown). Zebrafish infected with wild-type M. marinum all died by 20 days postinfection ( Figure 5A ). eccA1::Tn showed only a small loss of virulence in this experiment, but a higher-infecting inoculum was used here compared to a previous study (Gao et al., 2004) . Expression of wild-type EccA1 in eccA1::Tn restored the small loss of virulence, but ATPase-defective EccA1 markedly attenuated the eccA1::Tn strain. By the time (eccA1::Tn)/EQ-infected zebrafish began to die 24 days postinfection, all the zebrafish infected with wild-type, eccA1::Tn, or (eccA1::Tn)/WT had died ( Figure 5A ).
To explore this in vivo result, we determined the effects of EQ EccA1 on M. marinum growth. All strains grew similarly in 7H9 
Figure 5. EQ EccA1 Further Decreases Virulence and Intracellular Growth
(A) An EQ-expressing integrant strain is attenuated for zebrafish killing (****p % 0.002 compared to wild-type, logrank test; n R 5 for each strain). (B) All strains grew similarly in 7H9 media. (C) eccA1::Tn is defective for intracellular growth in bone marrow-derived macrophages. Wild-type EccA1 complements this defect, but EQ EccA1 worsens growth. Data are averaged from three independent experiments (**p % 0.03; ***p % 0.01; ****p % 0.002). broth ( Figure 5B ). eccA1::Tn showed mildly decreased growth in primary bone marrowderived macrophages, a defect fully complemented by expression of wild-type protein.
In contrast, expression of EQ EccA1 markedly diminished growth of eccA1::Tn in macrophages ( Figure 5C ). Statistical analyses revealed significant differences between both eccA1::Tn and (eccA1::Tn)/EQ with wild-type or (eccA1::Tn)/WT after 48 hr. These data demonstrate that EQ EccA1 diminishes bacterial virulence in the absence of wild-type EccA1, a circumstance in which ESX-1-dependent secretion is already lost.
DISCUSSION
Current models suggest that the mycobacterial ESX-1 system affects virulence through secretion of protein effectors with host-modulatory effects. Mycobacterial cell-wall lipids also are known to be important for virulence, but there has been little evidence for crosstalk between these key mechanisms of pathogenesis. Our studies suggest that EccA1, a core component of the ESX-1 secretion system (Abdallah et al., 2007; Bitter et al., 2009 ), physically associates with multiple lipid synthases, preferentially in the ATP-bound state. Disruption of EccA1 ATPase activity creates more stable interactions with these critical cellular enzymes. The functional importance of these interactions is supported by the observation that eccA1::Tn mycobacteria make less mycolic acid compared to strains expressing wild-type EccA1. Furthermore, we suggest that expression of ATPase-deficient EccA1 worsens mycolate synthesis when the synthesis system is under stress, perhaps because it sequesters enzymes required for efficient mycolate production.
Based on this, we propose that a normal role for EccA1 is to make mycolate synthesis more efficient, perhaps by shuttling relevant enzymes to sites of mycolate production ( Figure 6 ). This is an unexpected role for an ATPase that also has a more expected role in ESX-1-mediated substrate transport out of the mycobacterial cell. In this way, EccA1 ties together two of the most important virulence mechanisms of pathogenic mycobacteria, ESX-1-mediated secretion and synthesis of its hydrophobic cell envelope. We speculate that the decreased pathogenicity of an M. marinum strain expressing the EQ mutant may be due to its interference with mycolic acid synthesis, beyond the defects found in eccA1::Tn. Whereas absence of EccA1 appears to be sufficient to abolish ESX-1-mediated secretion, at least of ESAT-6, CFP-10 (Gao et al., 2004) , and EspE (M. marinum MMAR_5439; M. tuberculosis Rv3864) (Carlsson et al., 2009) , the ATPase-defective EccA1 further inhibits mycolate production under conditions of bacterial stress. This correlates with decreased pathogenesis, even when ESX-1-mediated secretion is already absent due to loss of EccA1. It is well known that different mutations in the esx-1 locus exhibit varying severities in virulence loss or intracellular growth, despite the fact that all block secretion (Abdallah et al., 2007; Gao et al., 2004; McLaughlin et al., 2007) . We speculate that other genes in the ESX-1 locus besides EccA1 also may contribute to cellenvelope synthesis, and thus have more than one mechanism by which they mediate virulence. For efficient mycolic acid production, EccA1 must interact with FAS-II components such as Pks13, KasB, and KasA (A-C), and release them in an ATP hydrolysislinked manner to the rest of FAS-II (D). (eccA1::Tn)/EQ is further sensitized to mycolic acid stress, relative to eccA1::Tn, because it has a lower amount of fully functioning Pks13, KasB, and KasA, important in (D). EccA1's interactions with these partner proteins are shown to be direct and exclusive here, but other mycobacterial proteins may aid these interactions or be part of these complexes. Three ATPs (shown in red) are bound to hexameric EccA1 here, but the real number is unknown.
SIGNIFICANCE
Tuberculosis is an unsolved medical problem with major global health and economic impact that has worsened because of the HIV epidemic. Multidrug resistance is on the rise, making some cases of the disease almost untreatable. Despite this, relatively few disease-causing mechanisms are understood for the causative bacterium, M. tuberculosis, and increased understanding is needed before new drug targets are identified and new therapies are developed. The best-characterized mycobacterial disease-related systems are the ESX-1 protein virulence factor export system and the waxy cell envelope composed largely of mycolic acids, which renders the bacteria resistant to host attack. Our studies on EccA1, a protein that is a component of the ESX-1 system, reveal that EccA1 has an unexpected role in regulating mycolic acid lipid synthesis via interaction with mycolic acid biosynthetic enzymes. This interesting link between these two key disease-causing mechanisms indicates that EccA1 represents an ''Achilles' heel'' affecting two pathways of mycobacterial biology that could be an appealing drug target for future therapeutic development.
EXPERIMENTAL PROCEDURES DNA eccA1 (MMAR_5443) was PCR amplified from M. marinum genomic DNA, and an N-terminal histidine tag was added. This product was cloned into pLYG206 (Gao et al., 2004) downstream of the hsp60 promoter to produce pWT68. The E398Q mutation was introduced into pWT68 using overlap extension PCR mutagenesis to produce pEQ68. In order to integrate these eccA1 variants, we excised the genes from pWT68 and pEQ68 and ligated them into pMV306, which is an integrative vector derived from pMV361 (Stover et al., 1991) . For protein expression, we used pET-22b (Novagen) after removing its pelB sequence. All construct sequences were verified by DNA sequencing.
Bacterial Strains
M. marinum strain M was used in these studies. The eccA1::Tn strain is equivalent to the previously published M3 strain (Gao et al., 2004) . Mycobacterial cultures were grown in 7H9 media containing ADC supplement (BD Biosciences), 0.2% glycerol, and 0.05% Tween 80. 7H10 agar plates contained OADC supplement. DNA was introduced into mycobacteria using electroporation. To integrate the eccA1 variants, the different pMV306 constructs were electroporated into eccA1::Tn M. marinum and plated on 7H10 agar plates containing 50 mg/ml hygromycin. Hyg R colonies were grown in liquid culture, and total cell lysates were screened for EccA1 production by immunoblotting using an anti-EccA1 antibody (see below). BL21-CodonPlus (DE3)-RP E. coli (Stratagene) was used for protein expression and purification.
Antibodies
Rabbit polyclonal antibodies were generated against EccA1, Pks13 (MMAR_5364), and Mas (MMAR_1767), using either protein or peptide antigens. A His-tagged EccA1 N-terminal fragment containing amino acids 1-298 was purified using Ni-NTA chromatography under denaturing conditions and used to raise the anti-EccA1 antibody. The other two antibodies were raised against unique synthetic peptides conjugated to thyroglobulin. Peptides consisted of amino acids 1653-1670 (Pks13) or 876-889 (Mas), and their specific reactivities were verified ( Figure S2A ). Immunoblotting experiments additionally used commercial antibodies against GroEL (Enzo Life Sciences), ESAT-6 (Thermo Fisher Scientific), the antigen 85 complex (BEI Resources; NR-13800), lambda repressor (Agilent), and RNA polymerase subunit a (Neoclone).
Solutions
Solution A is 100 mM HEPES-KOH (pH 7.5), 10% glycerol, 0.01% Tween 80, and 50 mM imidazole. Solution B is 100 mM HEPES-KOH (pH 7.5), 10% glycerol, 0.01% Tween 80, 25 mM imidazole, 150 mM KCl, and 5 mM MgCl 2 . Solution C is identical to solution B except that it also contains 400 mM imidazole.
Functional Tests
Contact-dependent hemolysis assays were done as previously described (Gao et al., 2004 ) with a few changes. Mid-log-phase cultures were washed in Dulbecco's modified Eagle's medium without phenol red and incubated in a 2.5:1 ratio with sheep red blood cells in a 50 ml reaction for 2 hr. Zebrafish experiments were done with adult zebrafish (Zebrafish International Resource Center, University of Oregon) and at least five zebrafish were infected per tested mycobacterial strain. Mycobacteria (2 3 10 5 ) were injected intraperitoneally into each zebrafish and time to death was noted. Macrophage infections were done as previously described (Gao et al., 2004 ) with a multiplicity of infection of 3 using 129/SvJ bone marrow-derived macrophages, except that infected macrophages were lysed with 0.1% Triton X-100 before plating. Zebrafish studies followed the ethical guidelines of the M. marinum-zebrafish infection protocol (protocol 08-124), and macrophage infection studies followed a mouse bone marrow-derived macrophage protocol Research, 1996) .
Coprecipitation of EccA1-Containing Cytosolic Complexes and
Identification Using Mass Spectrometry M. marinum cultures grown in 7H9 media were washed in Sauton's minimal media (Teknova), inoculated into 100 ml Sauton's cultures, and grown to mid-log phase. Cytosolic fractions were collected from harvested, lysed, and fractionated mycobacteria as previously described (Carlsson et al., 2009) . Cytosols were diluted 2-fold with solution A to end up in solution B. Talon affinity resin (Clontech) equilibrated in solution B was added to the cytosols in an amount normalized to the cell pellet mass used to generate the cytosolic fraction. Cytosolic complexes containing His-tagged EccA1 variants were batch bound to Talon resin for 90 min at 4 C. Complexes were isolated after passing the cytosols through an empty column, washing the captured resin with ten column volumes of solution B, and eluting with five column volumes of solution C. Eluted complexes were mixed with SDS loading buffer, boiled, and run on 4%-20% Criterion gradient gels (Bio-Rad). After silver staining, visible bands of interest were excised and in-gel digested with trypsin. Extracted peptides were sequenced by liquid-chromatographycoupled ESI tandem MS (LC-MS/MS) on an LTQ-Orbitrap instrument (Thermo Fisher Scientific). Processed MS/MS spectra were searched against the M. marinum nonredundant database by using MASCOT (Matrix Science) as a search engine, and were visualized and validated using the Scaffold program (Proteome Software).
Bacterial Two-Hybrid Experiments
Interactions between EccA1 variants, PPE68 (MMAR_5448), Pks13 1-1340 , KasB (MMAR_3339), KasA (MMAR_3338), and MmaA4 (MMAR_0977) were tested using the BacterioMatch II system (Agilent). Because Pks13 (MMAR_5364) is a very large molecule that might not fold correctly in E. coli, only the first 1,340 amino acids were used (Singh et al., 2006) . EccA1 variants were cloned into the pTRG vector, whereas the other five tested proteins were cloned into the pBT vector. Cotransformations followed the manufacturer's protocol, and protein interaction percentages were determined from the ratio of colonies on selective plates to colonies on nonselective plates. Nonselective plates contained 25 mg/ml chloramphenicol, 12.5 mg/ml tetracycline, and 50 mM IPTG, whereas selective plates additionally contained 5 mM 3-amino-1,2,4-triazole. To test expression of these fusion proteins by immunoblotting, we first expressed the proteins using the manufacturer's protocol, except we induced expression in SOC media at 37 C with 50 mM IPTG.
Mycolic Acid Synthesis Tests
Early-log-phase mycobacterial cultures growing in Sauton's minimal media were diluted to an A 600 of 0.4 in 20 ml final volumes. [1-14 C]-tetracosanoic acid (Moravek) was added to 0.5 mCi/ml and cultures were labeled for 3 hr. For testing mycolic acid production in the presence of ethionamide, mycobacteria were grown in 15 ml 7H9 cultures in 50 ml tubes for 6 hr after being diluted to an initial A 600 of 0.3. Either 0.5 mg/ml ethionamide or an equal volume of ethanol was added to each culture, along with 0.4 mCi/ml [1-
14 C]-tetracosanoic acid, at the start of the experiment. Harvested cells were washed once in water before being resuspended in 500 ml water. Saponification, methylation, and purification to isolate mycolic acid methyl esters (MAMEs) followed an established protocol (Vilchè ze and Jacobs, 2007) . Washed MAMEs were dried under nitrogen gas and resuspended in dichloromethane, and equal counts were applied to analytical silica gel 60 HPTLC plates (EMD Chemicals). Plates were developed three sequential times with 95:5 hexanes/ethyl acetate and imaged using a Typhoon PhosphorImager (GE Healthcare), and ImageQuant TL (GE Healthcare) was used to quantitate bands on the TLC plates.
Antibiotic Growth-Inhibition Tests
Mid-to late-log-phase mycobacterial cultures grown in 7H9 rich media were diluted to an A 600 of 0.1. Two-fold serial dilutions of mycobacteria with ethionamide, rifampin, or erythromycin were performed and a final volume of 100 ml was dispensed into each well of a 96-well plate. The tested concentration ranges were 0.018-18 mg/ml (ethionamide), 0.027-28 mg/ml (rifampin), and 0.625-640 mg/ml (erythromycin). Plates were sealed with Parafilm and grown for 48 hr at 30 C with 105 rpm shaking. A 600 values were determined using a plate reader, and IC 50 values (m3) were determined after fitting the data to the four-parameter logistic equation (Baud, 1993) : y = m1 + m2/(1 + (x/m3) m4 ). Here, y is the observed growth expressed as a percentage of the maximal growth, x is the antibiotic concentration, m1 is the minimal growth asymptotic value, m2 is the difference between the maximal and minimal growth asymptotes, m3 is the IC 50 value, and m4 is the Hill coefficient for cooperativity.
Statistical Analyses
Statistical significance of the survival of zebrafish cohorts infected with different mycobacterial strains was determined using the log-rank test. Otherwise, significance was determined using one-way ANOVA testing across all the samples analyzed in a given experiment. When calculated F values were greater than critical F values in these analyses, Fisher's least significant difference post hoc tests were applied to determine pairwise significant differences. Nonsignificant F values were found in a subset of the macrophage infection samples (inocula, 4 hr time point, and 24 hr time point).
Significance is denoted in the figures as *p < 0.05; **p % 0.03; ***p % 0.01; and ****p % 0.002.
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